Clinical trial
A Pilot Study of the Feasibility and Accuracy of the TrueVie Continuous Glucose Monitoring System - A Non-Significant Risk Study
NCT05348928 is registered in ClinicalTrials.gov with Sinocare Meditech Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of the Feasibility and Accuracy of the TrueVie Continuous Glucose Monitoring System - A Non-Significant Risk Study
- Lead sponsor
- Sinocare Meditech Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 4, 2022
- Completion date
- June 16, 2022
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
continuous glucose monitoring